176 related articles for article (PubMed ID: 37088477)
21. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
Oda H; Miyauchi A; Ito Y; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Endocr J; 2017 Jan; 64(1):59-64. PubMed ID: 27667647
[TBL] [Abstract][Full Text] [Related]
22. Active surveillance as a management strategy for papillary thyroid microcarcinoma.
Zhang H; Zheng X; Liu J; Gao M; Qian B
Cancer Biol Med; 2020 Aug; 17(3):543-554. PubMed ID: 32944389
[TBL] [Abstract][Full Text] [Related]
23. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.
Ito Y; Miyauchi A; Oda H
Eur J Surg Oncol; 2018 Mar; 44(3):307-315. PubMed ID: 28343733
[TBL] [Abstract][Full Text] [Related]
24. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
25. A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Yoannidis T; Rotstein L; Gullane PJ; Gilbert RW; Pasternak JD; Brown DH; Eskander A; Almeida JR; Irish JC; Higgins K; Enepekides DJ; Monteiro E; Banerjee A; Shah M; Gooden E; Zahedi A; Korman M; Ezzat S; Jones JM; Rac VE; Tomlinson G; Stanimirovic A; Gafni A; Baxter NN; Goldstein DP
Thyroid; 2020 Jul; 30(7):999-1007. PubMed ID: 32126932
[No Abstract] [Full Text] [Related]
26. Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma.
Jeon MJ; Kim WG; Kim TY; Shong YK; Kim WB
Endocrinol Metab (Seoul); 2021 Aug; 36(4):717-724. PubMed ID: 34379969
[TBL] [Abstract][Full Text] [Related]
27. Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines.
Kim MJ; Moon JH; Lee EK; Song YS; Jung KY; Lee JY; Kim JH; Kim K; Park SK; Park YJ
Endocrinol Metab (Seoul); 2024 Feb; 39(1):47-60. PubMed ID: 38356210
[TBL] [Abstract][Full Text] [Related]
28. Observation versus thyroidectomy for papillary thyroid microcarcinoma in the elderly.
Megwalu UC
J Laryngol Otol; 2017 Feb; 131(2):173-176. PubMed ID: 28007045
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal Assessment of Quality of Life According to Treatment Options in Low-Risk Papillary Thyroid Microcarcinoma Patients: Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro).
Kong SH; Ryu J; Kim MJ; Cho SW; Song YS; Yi KH; Park DJ; Hwangbo Y; Lee YJ; Lee KE; Kim SJ; Jeong WJ; Chung EJ; Hah JH; Choi JY; Ryu CH; Jung YS; Moon JH; Lee EK; Park YJ
Thyroid; 2019 Aug; 29(8):1089-1096. PubMed ID: 31161898
[No Abstract] [Full Text] [Related]
30. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
Griffin A; Brito JP; Bahl M; Hoang JK
Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
[TBL] [Abstract][Full Text] [Related]
31. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
Miyauchi A; Ito Y; Oda H
Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
[TBL] [Abstract][Full Text] [Related]
32. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.
Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735
[TBL] [Abstract][Full Text] [Related]
33. Papillary thyroid microcarcinoma: Is active surveillance always enough?
Sutherland R; Tsang V; Clifton-Bligh RJ; Gild ML
Clin Endocrinol (Oxf); 2021 Dec; 95(6):811-817. PubMed ID: 34021503
[TBL] [Abstract][Full Text] [Related]
34. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
[TBL] [Abstract][Full Text] [Related]
35. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
36. NATIONAL SURVEY OF ENDOCRINOLOGISTS AND SURGEONS REGARDING ACTIVE SURVEILLANCE FOR LOW-RISK PAPILLARY THYROID CANCER.
Roman BR; Brito JP; Saucke MC; Lohia S; Jensen CB; Zaborek N; Jennings JL; Tuttle RM; Davies L; Pitt SC
Endocr Pract; 2021 Jan; 27(1):1-7. PubMed ID: 33471727
[TBL] [Abstract][Full Text] [Related]
37. Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma.
Moon JH; Ryu CH; Cho SW; Choi JY; Chung EJ; Hah JH; Hwangbo Y; Jeong WJ; Jung YS; Kim JH; Kim MJ; Kim SJ; Kim YK; Lee CY; Lee EK; Lee JY; Lee KE; Lee YJ; Lee Y; Yu HW; Park DJ; Ryu J; Park YJ
J Clin Endocrinol Metab; 2021 Mar; 106(3):724-735. PubMed ID: 33248442
[TBL] [Abstract][Full Text] [Related]
38. A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Gullane PJ; Monteiro E; Gooden E; Brown DH; Eskander A; Zahedi A; Chung J; Su J; Xu W; Ihekire O; Jones JM; Gafni A; Baxter NN; Goldstein DP;
Thyroid; 2022 Mar; 32(3):255-262. PubMed ID: 35019770
[No Abstract] [Full Text] [Related]
39. Comparison of Postoperative Unfavorable Events in Patients with Low-Risk Papillary Thyroid Carcinoma: Immediate Surgery Versus Conversion Surgery Following Active Surveillance.
Sasaki T; Miyauchi A; Fujishima M; Ito Y; Kudo T; Noda T; Sano T; Kishi T; Nakamura T
Thyroid; 2023 Feb; 33(2):186-191. PubMed ID: 36205580
[No Abstract] [Full Text] [Related]
40. Evolving management considerations in active surveillance for micropapillary thyroid carcinoma.
Ho AS; Chen I; Melany M; Sacks WL
Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):353-359. PubMed ID: 30153222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
